Tempo Automation completes SPAC transaction and begins trading on NASDAQ under ticker TMPO



Comments are closed.

M3 Biotechnology Launches Clinical Trials for Alzheimer’s Disease Therapeutic
New Funding Advances M3 Biotechnology Toward Human Trials For Alzheimer’s Disease Therapeutic
Motif Neurotech closes Series A financing of $18.75 million
Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases